164MO Impaired Ki67 response towards neoadjuvant endocrine therapy in luminal breast cancer is associated with mutations conferring endocrine resistance: WSG-ADAPT HR+/HER2- translational results
| Autor: | Grote, I., Bartels, S., Kandt, L., Bollmann, L., Christgen, H., Gronewold, M., Gluz, O., Nitz, U., Kümmel, S., Braun, M., Aktas, B., Grischke, E-M., Schumacher, C., Lüdtke-Heckenkamp, K., Kates, R., Wuerstlein, R., Gräser, M., Harbeck, N., Christgen, M., Kreipe, H. |
|---|---|
| Zdroj: | In Annals of Oncology September 2020 31 Supplement 4:S306-S306 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|